Immune-Related Adverse Events: Findings From a Population-Based Study.
Nearly half of patients experienced at least one hospitalization with an irAE recorded as the main discharge diagnosis within 6 months after ICI initiation, underscoring the importance of monitoring and management to reduce patient and healthcare impact.